Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 30 January 2020 |
| Author/s |
author: Georgina V. Long Axel Hauschild Reinhard Dummer Keith Flaherty Dirk Schadendorf |
| Publication date | January 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |